aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 0.00 (-1.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Other Non-Current Liabilities (2014 - 2016)

Updated

aTYR PHARMA (ATYR) reported Other Non-Current Liabilities of $557,000 for Q1 2016, up 46.6% from $380,000 a year earlier but down 2.5% from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Other Non-Current Liabilities (2014 - 2016) Analysis & Trends

At the end of FY2015, aTYR PHARMA posted Other Non-Current Liabilities of $571,000, up 28.3% from FY2014.

  • By year, Other Non-Current Liabilities came in at $445,000 in FY2014.
  • Five-year quarterly Other Non-Current Liabilities spans a low of $380,000 in Q1 2015 and a high of $588,000 in Q2 2015.
  • Per Business Quant data, the three quarters before Q1 2016 came in at $571,000 (Q4 2015), $585,000 (Q3 2015) and $588,000 (Q2 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 aTYR PHARMA 16.86 Mn -275.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 606,000.00
Dec 31, 2015 701,000.00
Sep 30, 2015 796,000.00
Jun 30, 2015 879,000.00
Mar 31, 2015 991,000.00
Dec 31, 2014 1.10 Mn
API Access

aTYR PHARMA Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ATYR&period=max&api_key=YOUR_API_KEY